Sort
30,917 grants matching “tumor microenvironment”
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
$490,842Eun-Sil Shelley Hwang · Duke University · R01 · FY2015 · CA
A New Paradigm to Prevent and Treat Micrometastases
$490,840Timothy P Cripe · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$490,839Chad A. Mirkin · Northwestern University · R01 · FY2024 · CA
Elucidating the mechanisms that are responsible for the stability of cancer cell state
$490,784Barry H Honig · Columbia University Health Sciences · U54 · FY2017 · CA
Elucidating the mechanisms that are responsible for the stability of cancer cell state
$490,784Barry H Honig · Columbia University Health Sciences · U54 · FY2016 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$490,701Zena Werb · University Of California, San Francisco · R01 · FY2013 · CA
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma
$490,666Erik Sulman · New York University School Of Medicine · R01 · FY2020 · CA
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$490,646Chintan Parekh · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI
Controlling cancer with aspirin-triggered stimulation of resolution
$490,642Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Aaron F Straight · Stanford University · R01 · FY2023 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Lingyin Li · Stanford University · R01 · FY2022 · CA
Regulation of Mast Cell Proteases
$490,607Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2007 · HL
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2024 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2023 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2025 · AI
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
$490,590Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Artemin overexpression in oral cancer pain and carcinogenesis
$490,586Donna G Albertson · New York University · R01 · FY2021 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$490,568Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2022 · CA
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2025 · CA
Hexokinase 2 and cancer therapy
$490,487Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$490,448Bryan Quilty Spring · Northeastern University · U01 · FY2024 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$490,425Xin Wei Wang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
$490,281Teresa L Wood · Rbhs-New Jersey Medical School · R01 · FY2019 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$490,237Scott Andrew Gerber · University Of Rochester · R01 · FY2024 · CA